Voting Rights Announcement from

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

Vita 34 AG 

16.02.2015 14:55

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of voting rights pursuant to Art. 25, Sec. 1 WpHG
We received the following notification pursuant to Art. 25, Sec. 1 WpHG on
February 11, 2015:

1. Listed company:
Vita 34 AG
Deutscher Platz 5a, 04103 Leipzig, Germany

2. Notifier:
Human Stem Cells Institute OJSC, Moscow, Russian Federation 

3. Triggering event:
Exceeding Threshold

4. Threshold(s) crossed or reached:
5% and 10%

5. Date at which the threshold is crossed or reached:

6. Total amount of voting rights:
11.21% (equals 339462 voting rights)
calculated from the following total number of voting rights issued: 3026500

7. Detailed information on the voting rights proportion:

Voting rights proportion based on financial/other instruments pursuant to
Art. 25 WpHG:
2.64% (equals 80000 voting rights)

thereof held indirectly:
0% (equals 0 voting rights)

Voting rights pursuant to Art. 21, 22 WpHG:
8.57% (equals 259462 voting rights)

8. Detailed information on financial/other instruments pursuant to Art. 25

Exercise period: Any time

16.02.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at and

Language:     English
Company:      Vita 34 AG
              Deutscher Platz 5a
              04103 Leipzig
End of Announcement                             DGAP News-Service